Magenta Therapeutics
+$0.82 (+7.78%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell MGTA and other stocks, options, and ETFs commission-free!
About MGTA
Magenta Therapeutics, Inc. Common Stock, also called Magenta Therapeutics, is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants.
CEO
Jason Gardner
Employees
69
Headquarters
Cambridge, Massachusetts
Founded
2015
MGTA Key Statistics
Market Cap
600.06M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
122.27K
High Today
$11.59
Low Today
$10.75
Open Price
$10.88
Volume
150.57K
52 Week High
$14.20
52 Week Low
$6.03
MGTA Earnings
-$0.59
-$0.39
-$0.20
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.41 per share
Actual
-$0.36 per share